- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07938788
Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism
This randomized, controlled, crossover dietary intervention will test whether a three-week diverse diet, compared with a control diet with lower food diversity, changes postprandial insulin responses, other metabolic parameters, and the gut microbiome in 34 healthy adults with overweight. Participants will complete both diets in a randomized order, separated by a four-week washout period. The intervention periods will be conducted under free-living conditions, with study foods provided by the research center. Before and after each intervention period, postprandial metabolism will be assessed using standardized meal tests conducted under controlled whole-room calorimetry conditions. The primary outcome is the log-transformed total postprandial insulin area under the concentration-time curve from 0 to 240 minutes.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Anja Bosy-Westphal, Prof. Dr. Dr.
- Telefonnummer: +49 431 880 5674
- E-Mail: abosyw@nutrition.uni-kiel.de
Studienorte
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Deutschland, 24105
- Institute of Human Nutrition and Food Science , Department Human Nutrition
-
Kontakt:
- Anja Bosy-Westphal
- Telefonnummer: +49 431 880 5674
- E-Mail: abosyw@nutrition.uni-kiel.de
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Healthy adults with overweight.
- Age 18-60 years.
- Body mass index (BMI) >=25 and <30 kg/m2.
- Men and women; the study plans an equal distribution of biological sex.
- No regular sports participation; regular sporting activity >=2 h/week is excluded.
- German-speaking, because the study questionnaires are in German and not validated in other languages.
- No anemia or iron deficiency based on screening hemoglobin and ferritin.
- Women of childbearing potential must use hormonal contraception (e.g., pill, hormonal IUD, contraceptive patch, vaginal ring, 3-month injection, or hormonal implant) and have pregnancy excluded by hCG testing.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- - Individuals unable to provide informed written consent.
- Vegetarian or vegan diet.
- Habitual consumption of more than 5 caffeinated beverages per day.
- Chronic diseases.
- Regular medication use, except oral contraceptives.
- Antibiotic use within 6 weeks before study start.
- Anemia and/or iron deficiency.
- Pregnancy or breastfeeding.
- Cigarette and/or cannabis use, including vaping.
- Food allergies and/or food intolerances.
- Current weight-reduction diet or weight loss >5 kg within the previous 3 months.
- Regular sporting activity >=2 h/week.
- Claustrophobia/fear of confined spaces because of EchoMRI assessment.
- Active participation in another study.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Control Diet -> Diverse Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
|
Experimental: Diverse Diet -> Control Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Postprandial Insulin
Zeitfenster: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Postprandial Glucose
Zeitfenster: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
C-Peptide
Zeitfenster: 24 hours
|
Urinary c-peptide excretion during the 24h stay in the whole-room indirect calorimeter. |
24 hours
|
|
Non-esterified fatty acids
Zeitfenster: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Triglycerides
Zeitfenster: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Appetite-relatied hormones (GLP-1, PYY, Ghrelin)
Zeitfenster: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Subjective Appetite
Zeitfenster: 0-300 minutes
|
measured with visual analogue scales (5 hours AUC; mm x 5 hours) after a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side. |
0-300 minutes
|
|
Energy Expenditure and macronutrient oxidation
Zeitfenster: 24 hours
|
measured during the 24h stay with indirect calorimetry in a whole-room indirect calorimeter (kcal/day) at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
24 hours
|
|
Gut microbiome composition and Microbiome diversity
Zeitfenster: Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
taxonomy and function via shotgun metagenome sequencing |
Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- ABW-2026-GRK
- 54453043/GRK3128 (Andere Zuschuss-/Finanzierungsnummer: DFG)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .